Review of treatment options for oligometastatic non–small cell lung cancer

Michael R. Folkert, Robert Timmerman

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Our understanding of metastatic disease is constantly evolving. Although outcomes for patients with stage IV non–small cell lung cancer (NSCLC) are poor, aggressive/radical local intervention may be effective in a subset of patients with limited or “oligometastatic” disease. Here we review and compare the range of available treatment options that are specific to oligometastatic NSCLC, and discuss potential directions of future clinical research.

Original languageEnglish (US)
Pages (from-to)186-193
Number of pages8
JournalClinical Advances in Hematology and Oncology
Issue number3
StatePublished - Jan 1 2015


  • Limited metastatic disease
  • Non–small cell lung cancer
  • Oligometastases
  • Stereotactic radiation

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Review of treatment options for oligometastatic non–small cell lung cancer'. Together they form a unique fingerprint.

Cite this